Investigators at Emory University Detail Findings in Breast Cancer (Pharmacological Suppression of the Otud4/cd73 Proteolytic Axis Revives Antitumor Immunity Against Immune-suppressive Breast Cancers)

    Press/Media: Press / Media

    PeriodAug 1 2024